6 completed, 1 unknown. 7 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 7 | Completed 6, Unknown 1 |
Follow Interferons: new trials by email Literature Review of Interferons trials Research Report on Interferons
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Discontinuing Disease-modifying Therapies in Stable Relapsing - Onset Multiple Sclerosis (DOT-MS). DMT - Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting | Not applicable | Unknown | Amsterdam UMC, location VUmc | 130 | 2020-07-01 | 2020-10-19 |
| Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial Natalizumab/natalizumab-sztn, Alemtuzumab, Ocrelizumab, Rituximab/rituximab-arrx/rituximab-abbs/rituximab-pvvr, Cladribine, Ofatumumab, Ublituximab-xiiy, Ocrelizumab and hyaluronidase-ocsq, Glatiramer acetate, Interferons (intramuscular, subcutaneous, pegylated) Teriflunomide, Fumarates (dimethyl, diroximel, monomethyl) Fingolimod, Siponimod, Ozanimod, Ponesimod - Multiple Sclerosis, Relapsing-Remitting | Not applicable | Completed | Johns Hopkins University | 900 | 2018-05-02 | 2026-09-23 |
| The Curative Effect and Security of Interferon Combined Resveratrol on HBeAg Positive Chronic Hepatitis B Patients Interferon, Interferon+resveratrol - Hepatitis B, Interferon | Not applicable | Completed | The First Hospital of Jilin University | 228 | 2016-06-01 | 2020-10-14 |
| Intravenous Interferon During Liver Transplant IV interferon - Hepatitis C, Cirrhosis | Not applicable | Completed | Wake Forest University Health Sciences | 15 | 2009-10-01 | 2022-04-21 |
| Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS) Interferon and ribavirin - Hepatitis C, Chronic, Cognition Disorders | Not applicable | Completed | Aarhus University Hospital | 100 | 2008-11-01 | 2013-01-11 |
| Phase II Trial of Concurrent Administration of Intravesical BCG & Interferon in the Treatment and Prevention of Recurrence of Superficial Transitional Carcinoma of the Urinary Bladder BCG, Interferon - Transitional Carcinoma of Urinary Bladder | Not applicable | Completed | King Faisal Specialist Hospital & Research Center | 10 | 2007-09-01 | 2015-12-17 |
| Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV Treatment pegylated interferon-alpha (Pegasys), ribavirin (COPEGUS) - Human Immunodeficiency Virus, Chronic Hepatitis C | Not applicable | Completed | Karolinska Institutet | 25 | 2009-05-27 |
Hepatitis C, Chronic (2) · Multiple Sclerosis, Relapsing-Remitting (2) · Acquired Immunodeficiency Syndrome (1) · Cognition Disorders (1) · Cognitive Dysfunction (1) · Depressive Disorder, Major (1) · Fatigue Syndrome, Chronic (1) · Fibrosis (1) · Hepatitis B (1) · Hepatitis C (1) · Multiple Sclerosis (1) · Multiple Sclerosis, Chronic Progressive (1)
Aarhus University Hospital (1) · Amsterdam UMC, location VUmc (1) · Johns Hopkins University (1) · Karolinska Institutet (1) · King Faisal Specialist Hospital & Research Center (1) · The First Hospital of Jilin University (1) · Wake Forest University Health Sciences (1)
Denmark (1) · Netherlands (1) · Sweden (1) · United States (1)
Annette Alaeus, MD;PhD (1) · Ellen M. Mowry, MD, MCR (1) · J. Killestein, prof. dr. (1) · Junqi Niu, PHD (1) · Mark W Russo, MD, MPH (1) · Peter Leutscher, MD, PhD (1) · Scott D. Newsome, DO (1) · Shouki Bazarbashi, MD (1)
PMID 18495540, PMID 20608766, PMID 33407619, PMID 38654416, PMID 39652340